- NORTH AMERICA EDITIONAustraliaNorth AmericaWorld
Featured Articles and Interviews
Aug 14, 2025
Top 5 Small-cap Pharma Stocks of 2025
Aug 12, 2025
5 Biggest Pharmaceutical ETFs in 2025
Jul 24, 2025
Biotech and Pharma Market Update: Q2 2025 in Review
More Featured Articles and Inverviews
Press Releases
Oct 07, 2025
Merck Completes Acquisition of Verona Pharma
More Press Releases
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.